Studies have shown that activated T cells, particularly CD8+ T cells, are the primary cellular target of EBV infection in sporadic EBV-HLH [9,10], which reflects the pathogenic role of EBV-infected CD8+ T cells in sporadic EBV-HLH. This evidence concerns the gene CD8A and Epstein-Barr virus infection.